CLINICAL_TRIALS
trial_result
· 2011-02-14
Clinical Trial Update: Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia [Phase 3]
Summary
Phase 3 trial of lurasidone hydrochloride for acute schizophrenia has completed. Results from the study were posted on 2011-02-14.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2011-02-14